A protocol for developing a core outcome set for ectopic pregnancy.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
17 Nov 2021
Historique:
received: 08 04 2021
accepted: 29 10 2021
entrez: 18 11 2021
pubmed: 19 11 2021
medline: 20 11 2021
Statut: epublish

Résumé

Randomised controlled trials (RCTs) evaluating ectopic pregnancy have reported many different outcomes, which are themselves often defined and measured in distinct ways. This level of variation results in an inability to compare results of individual RCTs. The development of a core outcome set to ensure outcomes important to key stakeholders are collected consistently will guide future research in ectopic pregnancy. To develop and implement a core outcome set to guide future research in ectopic pregnancy. We have established an international steering group of key stakeholders, including healthcare professionals, researchers, and individuals with lived experience of ectopic pregnancy. We will identify potential outcomes from ectopic pregnancy from a comprehensive literature review of published randomised controlled trials. We will then utilise a modified Delphi method to prioritise outcomes. Subsequently, key stakeholders will be invited to score potential core outcomes on a nine-point Likert scale, ranging from 1 (not important) to 9 (critical). Repeated reflection and rescoring should promote whole and individual stakeholder group convergence towards consensus 'core' outcomes. We will also establish standardised definitions and recommend high-quality measurements for individual core outcomes. COMET 1492 . Registered in November 2019.

Sections du résumé

BACKGROUND BACKGROUND
Randomised controlled trials (RCTs) evaluating ectopic pregnancy have reported many different outcomes, which are themselves often defined and measured in distinct ways. This level of variation results in an inability to compare results of individual RCTs. The development of a core outcome set to ensure outcomes important to key stakeholders are collected consistently will guide future research in ectopic pregnancy.
STUDY AIM OBJECTIVE
To develop and implement a core outcome set to guide future research in ectopic pregnancy.
METHODS AND ANALYSIS METHODS
We have established an international steering group of key stakeholders, including healthcare professionals, researchers, and individuals with lived experience of ectopic pregnancy. We will identify potential outcomes from ectopic pregnancy from a comprehensive literature review of published randomised controlled trials. We will then utilise a modified Delphi method to prioritise outcomes. Subsequently, key stakeholders will be invited to score potential core outcomes on a nine-point Likert scale, ranging from 1 (not important) to 9 (critical). Repeated reflection and rescoring should promote whole and individual stakeholder group convergence towards consensus 'core' outcomes. We will also establish standardised definitions and recommend high-quality measurements for individual core outcomes.
TRIAL REGISTRATION BACKGROUND
COMET 1492 . Registered in November 2019.

Identifiants

pubmed: 34789295
doi: 10.1186/s13063-021-05772-x
pii: 10.1186/s13063-021-05772-x
pmc: PMC8596090
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

813

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
PLoS Med. 2011 Jan 25;8(1):e1000393
pubmed: 21283604
Obstet Gynecol. 2016 Jan;127(1):49-58
pubmed: 26646133
BJOG. 2017 Feb;124(3):366-369
pubmed: 28120536
Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:134-142
pubmed: 31901601
Hum Reprod. 2020 Feb 29;35(2):404-412
pubmed: 32020203
Fertil Steril. 2011 Mar 1;95(3):857-66
pubmed: 20947073
N Engl J Med. 2009 Jul 23;361(4):379-87
pubmed: 19625718
Trials. 2019 Feb 11;20(1):116
pubmed: 30744706
Aust N Z J Obstet Gynaecol. 2014 Aug;54(4):298-9
pubmed: 25117187
Lancet. 2014 Apr 26;383(9927):1483-1489
pubmed: 24499812
Hum Reprod. 2007 Nov;22(11):2824-8
pubmed: 17855406
Trials. 2012 Aug 06;13:132
pubmed: 22867278
J Clin Epidemiol. 2011 Apr;64(4):395-400
pubmed: 21194891
Hum Reprod Open. 2018 Jun 15;2018(3):hoy007
pubmed: 30895248
Australas J Ultrasound Med. 2011 May;14(2):29-33
pubmed: 28191110
BMJ Open. 2016 Dec 21;6(12):e013998
pubmed: 28003300
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707

Auteurs

Krystle Y Chong (KY)

Monash Women's, Monash Health, Clayton, Australia. drkrystlechong@gmail.com.
Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia. drkrystlechong@gmail.com.

Sarah Solangon (S)

Institute for Women's Health, University College London, London, UK.

James Kemper (J)

Monash Women's, Monash Health, Clayton, Australia.

Kurt Barnhart (K)

Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Penn Medicine/University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Pamela Causa Andrieu (PC)

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.
Radiology Service, Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina.

Perrine Capmas (P)

Department of obstetrics and Gynecology, Bicetre University Hospital, Paris Saclay University, Le Kremlin Bicêtre, France.

Carolina Chacon (C)

Radiology Service, Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina.

George Condous (G)

Acute Gynaecology, Early Pregnancy and Advanced Endosurgery Unit, Sydney Medical School Nepean, University of Sydney, Nepean Hospital, Camperdown, NSW, Australia.

Liesl de Waard (L)

Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

James M N Duffy (JMN)

Institute for Women's Health, University College London, London, UK.
King's Fertility, Fetal Medicine Research Institute, London, UK.

Andrew Horne (A)

MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, EH16 4TJ, UK.

Maria Memtsa (M)

Institute for Women's Health, University College London, London, UK.

Femke Mol (F)

Center for Reproductive Medicine, Amsterdam Reproduction & Development Research Institute, Amsterdam, UMC, Netherlands.

Munira Oza (M)

The Ectopic Pregnancy Trust, London, UK.

Annika Strandell (A)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Madelon van Wely (M)

Center for Reproductive Medicine, Amsterdam Reproduction & Development Research Institute, Amsterdam, UMC, Netherlands.

Janneke Van't Hooft (J)

Department of Obstetrics and Gynaecology, Amsterdam UMC, Amsterdam, The Netherlands.

Lan N Vuong (LN)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.

Jian Zhang (J)

Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Davor Jurkovic (D)

Institute for Women's Health, University College London, London, UK.

Ben W Mol (BW)

Monash Women's, Monash Health, Clayton, Australia.
Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH